Hospitals Warn CGHS Reimbursement Cap Threatens Cancer Treatment
A major private hospital group has warned that the Central Government Health Scheme's reimbursement cap on life-saving immunotherapy drugs is causing financial strain and threatening access to advanced cancer treatments. The association identified nine specific immunotherapy drugs that have become unaffordable for many CGHS beneficiaries, potentially impacting patient care.
The Economic Times·


